| 1 |
凌 芸. 液体活检技术在肺癌辅助诊断中的应用研究进展[J]. 智慧健康，2021, 7(2): 4.
|
| 2 |
Allard WJ. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases[J]. Clin Cancer Res, 2004, 10(20): 6897-6904.
|
| 3 |
Dianat-Moghadam H, Mahari A, Heidarifard M, et al. NK cells-directed therapies target circulating tumor cells and metastasis[J]. Cancer Lett, 2021, 497: 41-53.
|
| 4 |
Bhojnagarwala PS, Perales-Puchalt A, Cooch N, et al. A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust Tcell generation[J]. Mol Ther Oncolytics, 2021, 21: 278-287.
|
| 5 |
Wang L, Wu C, Qiao L, et al. Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer[J]. J Cancer, 2017, 8(1): 104-110.
|
| 6 |
Yin W, Zhu J, Ma B, et al. Overcoming obstacles in pathological diagnosis of pulmonary nodules through circulating tumor cell enrichment[J]. Small, 2020，16(25): e2001695.
|
| 7 |
Marianna G, Antonella DL, Rosaria MM, et al. Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer[J]. Transl Lung Cancer Res, 2017, 6(4): 486-498.
|
| 8 |
Chen L, Peng M, Li N, et al. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer[J]. Scient Rep, 2018, 8(1): 1188.
|
| 9 |
Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells.[J]. N Engl J Med, 2008, 359(4): 366-377.
|
| 10 |
吴颖虹，王仁杰，胡文杰，等. 循环肿瘤细胞在晚期非小细胞肺癌顺铂联合多西他赛化疗疗效评价和预后评估中的作用[J]. 中国老年学杂志，2022, 42(7): 3.
|
| 11 |
徐 静，何 靓，钱慧珠，等. 循环肿瘤细胞检测在EGFR合并TP53突变的晚期非小细胞肺癌一代EGFR-TKI治疗中的疗效评价[J]. 医学研究生学报，2022, 35(3): 5.
|
| 12 |
Zheng H, Wu X, Yin J, et al. Clinical applications of liquid biopsies for early lung cancer detection[J]. Am J Cancer Res, 2019, 9(12): 2567-2579.
|
| 13 |
Yuichi Kumaki, Steve Olsen, Mitsukuni Suenaga, et al. MET Comprehensive genomic profiling of circulating cell-free DNA distinguishes focal amplification from aneuploidy in diverse advanced cancers.[J] . Curr Oncol, 2021, 28: 3717-3728.
|
| 14 |
Ryosuke F, Takeshi I, Fumitaka E, et al. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer[J]. Carcinogenesis, 2021, 42(10): 1239-1249.
|
| 15 |
Francesca Palmisani, Heinrich Kovar, Leo Kager, et al. Systematic review of the immunological landscape of Wilms tumors.[J]. Mol Ther Oncolytics, 2021, 22: 454-467.
|
| 16 |
Szczerba BM, Castro-Giner F, Vetter M, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression[J]. Nature, 2019, 566(7745): 553-557.
|
| 17 |
Zhang JT, Liu SY, Gao W, et al. Longitudinal undetectable molecular residual disease defines potentially cured population in localized non-small cell lung cancer[J] . Cancer Discov, 2022, 12: 1690-1701.
|
| 18 |
Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology[J]. Neurology, 1979, 29(10): 1369-1375.
|
| 19 |
张昆煜，戴朝霞，刘思雅，等. 脑脊液ctDNA对非小细胞肺癌脑膜转移患者的临床价值[J]. 中国肺癌杂志，2020, 23(12): 10.
|
| 20 |
刘 垚，钱有辉. ctDNA检测及靶向药物在非小细胞肺癌中的应用[J]. 医学信息，2020, 33(11): 4.
|
| 21 |
Decker CJ. The exosome: a versatile RNA processing machine[J] . Curr Biol, 1998, 8: R238-40.
|
| 22 |
Sun JB, Lu ZH, Fu W, et al. Exosome-derived ADAM17 promotes liver metastasis in colorectal cancer[J]. Front Pharmacol, 2021, 12: 734351.
|
| 23 |
Du JB, Wan Z, Wang C, et al. Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy[J] . Theranostics, 2021, 11: 8185-8196.
|
| 24 |
Stephen Cristiano, Alessandro Leal, Jillian Phallen, et al. Genome-wide cell-free DNA fragmentation in patients with cancer[J] . Nature, 2019, 570: 385-389.
|
| 25 |
Riccardo Cazzoli, Fiamma Buttitta, Marta Di Nicola, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer[J]. J Thorac Oncol, 2013, 8: 1156-1162.
|
| 26 |
Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing[J]. Clin Cancer Res, 2017, 23(17): 5311-5319.
|
| 27 |
Yuwen DL, Sheng BB, Liu J, et al. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.[J]. Eur Rev Med Pharmacol Sci, 2017, 21: 2650-2658.
|
| 28 |
Jiang CY, Zhang N, Hu XL, et al. Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms.[J]. Mol Cancer, 2021, 20: 117.
|
| 29 |
Wu SH, Hsieh CC, Hsu SC, et al. RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy[J]. J Adv Res, 2020, 30: 185-196.
|
| 30 |
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs[J]. Nat Rev Mol Cell Biol, 2020, 21: 475-490.
|
| 31 |
Wang YX, Liu JB, Ma JF, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases.[J]. Mol Cancer, 2019, 18: 116.
|
| 32 |
Liu ZH, Yang SZ, Chen XT, et al. Correlations of hsa_circ_0046264 expression with onset, pathological stage and chemotherapy resistance of lung cancer[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18): 9511-9521.
|
| 33 |
Liu XX, Yang YE, Liu X, et al. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma[J]. J Transl Med, 2019，17(1): 50.
|
| 34 |
Xian J, Su W, Liu L, et al. Identification of three circular RNA cargoes in serum exosomes as diagnostic biomarkers of non-small-cell lung cancer in the Chinese population[J]. J Mol Diagn, 2020, 22(8): 1096-1108.
|
| 35 |
Lu GJ, Cui J, Qian Q, et al. Overexpression of hsa_circ_0001715 is a potential diagnostic and prognostic biomarker in lung adenocarcinoma[J]. Onco Targets Ther, 2020, 13: 10775-10783.
|
| 36 |
Sacco JJ, Akhrass HA, Wilson CM. Challenges and strategies in precision medicine for non-small-cell lung cancer[J]. Current Pharmaceut Design, 2016, 22(28): 4374-4385.
|